Thirty Madison Raises $140M in Series C Funding
- Thirty Madison, a New York-based healthcare company that focuses on people with chronic conditions, raised $140M in Series C funding
- The round was led by new investor HealthQuest Capital with participation from Mousse Partners and Bracket Capital and existing investors
- In conjunction with the funding, Randy Scott, Partner at HealthQuest Capital, will join Jason Stoffer, Partner at Maveron
- The company, which has raised a total of $210m to date and is now valued at over $1B, intends to use the funds to expand access to its care model
- Thirty Madison is the premier healthcare company for people living with chronic conditions
- Its specialized care model, powered by a proprietary platform, provides care to an increasing number of patients
